Biocon LimitedNSE: BIOCON

Press Release Aug 29 2024

· Issued by Biocon Limited

Filed with NSE ·

Biocon Limited has informed the Exchange regarding a press release dated August 29, 2024, titled "Press Release titled Biocon Biologics Secures Market Entry for Bmab 1200, a Proposed Biosimilar to Stelara?, in Europe, UK, Canada, and Japan ".

View Attachment

6ix hasn’t read this filing yet.

Biocon Limited on 6ix

Earlier from Biocon

Later from Biocon

All Biocon news releases